Nicole L Byers

806 total citations
5 papers, 377 citations indexed

About

Nicole L Byers is a scholar working on Oncology, Rheumatology and Immunology. According to data from OpenAlex, Nicole L Byers has authored 5 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Rheumatology and 2 papers in Immunology. Recurrent topics in Nicole L Byers's work include Cytokine Signaling Pathways and Interactions (4 papers), Systemic Lupus Erythematosus Research (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Nicole L Byers is often cited by papers focused on Cytokine Signaling Pathways and Interactions (4 papers), Systemic Lupus Erythematosus Research (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Nicole L Byers collaborates with scholars based in United States, Japan and Austria. Nicole L Byers's co-authors include Terence Rooney, Guilherme Rocha, Richard E. Higgs, Steven H. Zuckerman, Peter C. Taylor, Iain B. McInnes, William L. Macias, Jonathan Lee, Robert Ortmann and Songqing Na and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Arthritis & Rheumatology.

In The Last Decade

Nicole L Byers

5 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicole L Byers United States	5	167	91	90	75	53	5	377
Irina Lazariciu United States	7	224 1.3×	80 0.9×	73 0.8×	119 1.6×	53 1.0×	13	342
Krishan Thirunavukkarasu Australia	7	292 1.7×	78 0.9×	121 1.3×	142 1.9×	59 1.1×	9	430
Laura Brockwell United Kingdom	5	172 1.0×	51 0.6×	71 0.8×	63 0.8×	33 0.6×	5	310
Piet L. van Riel Netherlands	11	209 1.3×	73 0.8×	146 1.6×	81 1.1×	29 0.5×	13	404
Juan S. Lasa Argentina	7	90 0.5×	70 0.8×	66 0.7×	47 0.6×	18 0.3×	19	355
Meilien Ho United Kingdom	11	168 1.0×	34 0.4×	60 0.7×	78 1.0×	69 1.3×	16	353
Kenneth Washenik United States	5	64 0.4×	52 0.6×	42 0.5×	132 1.8×	59 1.1×	7	409
Pintip Ngamjanyaporn Thailand	13	299 1.8×	48 0.5×	235 2.6×	33 0.4×	18 0.3×	32	509
Joern Kekow Germany	9	195 1.2×	52 0.6×	136 1.5×	144 1.9×	30 0.6×	10	425
Alina Onofrei United States	5	242 1.4×	38 0.4×	89 1.0×	93 1.2×	52 1.0×	9	372

Countries citing papers authored by Nicole L Byers

Since Specialization

Citations

This map shows the geographic impact of Nicole L Byers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole L Byers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole L Byers more than expected).

Fields of papers citing papers by Nicole L Byers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole L Byers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole L Byers. The network helps show where Nicole L Byers may publish in the future.

Co-authorship network of co-authors of Nicole L Byers

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole L Byers. A scholar is included among the top collaborators of Nicole L Byers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole L Byers. Nicole L Byers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Dörner, Thomas, Yoshiya Tanaka, Michelle Petri, et al.. (2020). Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Lupus Science & Medicine. 7(1). e000424–e000424. 43 indexed citations

2.

Winthrop, Kevin, Masayoshi Harigai, Mark C. Genovese, et al.. (2020). Infections in baricitinib clinical trials for patients with active rheumatoid arthritis. Annals of the Rheumatic Diseases. 79(10). 1290–1297. 66 indexed citations

3.

McInnes, Iain B., Nicole L Byers, Richard E. Higgs, et al.. (2019). Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations. Arthritis Research & Therapy. 21(1). 183–183. 208 indexed citations

4.

Tanaka, Yoshiya, Iain B. McInnes, Peter C. Taylor, et al.. (2018). Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 70(12). 1923–1932. 26 indexed citations

5.

Spaic, Tamara, Jeff Mahon, Irene Hramiak, et al.. (2013). Multicentre randomized controlled trial of structured transition on diabetes care management compared to standard diabetes care in adolescents and young adults with type 1 diabetes (Transition Trial). BMC Pediatrics. 13(1). 163–163. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact